Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Psychoemotional Status and Functional Gastrointestinal Disorders

This prospective cohort study will evaluate the influence of psychoemotional status on the clinical course and quality of life of adult patients with functional dyspepsia and/or irritable bowel syndrome diagnosed according to Rome IV criteria. The study aims to assess the contribution of affective and somatoform disorders to quality of life and symptom burden in these patients. In participants with functional dyspepsia, the association of Helicobacter pylori status with psychoemotional status and quality of life will also be evaluated. Patients will complete validated questionnaires assessing quality of life, depression, anxiety, and somatization at baseline and again during follow-up after treatment. Clinical symptoms, pain severity, stool characteristics, and H. pylori status will also be assessed as applicable.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Center of New Medical TechnologiesUpdated: Apr 20, 2026Locations: 1
Eligibility criteria

Age 18 years and older [+2]

Age younger than 18 years [+5]

Status: Recruiting

Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.

Participants needed: 100
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Center of New Medical TechnologiesUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Verified MS per NCEP-ATP III criteria. [+1]

Current metabolic-influencing therapy. [+8]